img

Global Paracetamol IV Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Paracetamol IV Market Research Report 2024

Paracetamol when given intravenously acts as an effective treatment option in relieving pain and gives rapid relief. Moreover, the use of intravenous paracetamol in combination with NSAIDs and narcotics has been gaining popularity and acceptance, which further propels the growth of the industry.
According to Mr Accuracy reports’s new survey, global Paracetamol IV market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Paracetamol IV market research.
Key companies engaged in the Paracetamol IV industry include Mallinckrodt (Mallinckrodt Pharmaceuticals), Cipla Inc., Lupin, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Novartis AG, Pfizer, Inc. and Abbott, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Paracetamol IV were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Paracetamol IV market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Paracetamol IV market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Mallinckrodt (Mallinckrodt Pharmaceuticals)
Cipla Inc.
Lupin
Dr. Reddy's Laboratories Ltd.
Aurobindo Pharma
Sun Pharmaceutical Industries Ltd.
Novartis AG
Pfizer, Inc.
Abbott
Sanofi
Bristol-Myers Squibb Company
Segment by Type
Pain
Pyrexia (Fever)

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Paracetamol IV report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paracetamol IV Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Pain
1.2.3 Pyrexia (Fever)
1.3 Market by Application
1.3.1 Global Paracetamol IV Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Paracetamol IV Market Perspective (2018-2034)
2.2 Paracetamol IV Growth Trends by Region
2.2.1 Global Paracetamol IV Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Paracetamol IV Historic Market Size by Region (2018-2023)
2.2.3 Paracetamol IV Forecasted Market Size by Region (2024-2034)
2.3 Paracetamol IV Market Dynamics
2.3.1 Paracetamol IV Industry Trends
2.3.2 Paracetamol IV Market Drivers
2.3.3 Paracetamol IV Market Challenges
2.3.4 Paracetamol IV Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Paracetamol IV Players by Revenue
3.1.1 Global Top Paracetamol IV Players by Revenue (2018-2023)
3.1.2 Global Paracetamol IV Revenue Market Share by Players (2018-2023)
3.2 Global Paracetamol IV Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Paracetamol IV Revenue
3.4 Global Paracetamol IV Market Concentration Ratio
3.4.1 Global Paracetamol IV Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paracetamol IV Revenue in 2024
3.5 Paracetamol IV Key Players Head office and Area Served
3.6 Key Players Paracetamol IV Product Solution and Service
3.7 Date of Enter into Paracetamol IV Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Paracetamol IV Breakdown Data by Type
4.1 Global Paracetamol IV Historic Market Size by Type (2018-2023)
4.2 Global Paracetamol IV Forecasted Market Size by Type (2024-2034)
5 Paracetamol IV Breakdown Data by Application
5.1 Global Paracetamol IV Historic Market Size by Application (2018-2023)
5.2 Global Paracetamol IV Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Paracetamol IV Market Size (2018-2034)
6.2 North America Paracetamol IV Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Paracetamol IV Market Size by Country (2018-2023)
6.4 North America Paracetamol IV Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Paracetamol IV Market Size (2018-2034)
7.2 Europe Paracetamol IV Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Paracetamol IV Market Size by Country (2018-2023)
7.4 Europe Paracetamol IV Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Paracetamol IV Market Size (2018-2034)
8.2 Asia-Pacific Paracetamol IV Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Paracetamol IV Market Size by Region (2018-2023)
8.4 Asia-Pacific Paracetamol IV Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Paracetamol IV Market Size (2018-2034)
9.2 Latin America Paracetamol IV Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Paracetamol IV Market Size by Country (2018-2023)
9.4 Latin America Paracetamol IV Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Paracetamol IV Market Size (2018-2034)
10.2 Middle East & Africa Paracetamol IV Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Paracetamol IV Market Size by Country (2018-2023)
10.4 Middle East & Africa Paracetamol IV Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mallinckrodt (Mallinckrodt Pharmaceuticals)
11.1.1 Mallinckrodt (Mallinckrodt Pharmaceuticals) Company Detail
11.1.2 Mallinckrodt (Mallinckrodt Pharmaceuticals) Business Overview
11.1.3 Mallinckrodt (Mallinckrodt Pharmaceuticals) Paracetamol IV Introduction
11.1.4 Mallinckrodt (Mallinckrodt Pharmaceuticals) Revenue in Paracetamol IV Business (2018-2023)
11.1.5 Mallinckrodt (Mallinckrodt Pharmaceuticals) Recent Development
11.2 Cipla Inc.
11.2.1 Cipla Inc. Company Detail
11.2.2 Cipla Inc. Business Overview
11.2.3 Cipla Inc. Paracetamol IV Introduction
11.2.4 Cipla Inc. Revenue in Paracetamol IV Business (2018-2023)
11.2.5 Cipla Inc. Recent Development
11.3 Lupin
11.3.1 Lupin Company Detail
11.3.2 Lupin Business Overview
11.3.3 Lupin Paracetamol IV Introduction
11.3.4 Lupin Revenue in Paracetamol IV Business (2018-2023)
11.3.5 Lupin Recent Development
11.4 Dr. Reddy's Laboratories Ltd.
11.4.1 Dr. Reddy's Laboratories Ltd. Company Detail
11.4.2 Dr. Reddy's Laboratories Ltd. Business Overview
11.4.3 Dr. Reddy's Laboratories Ltd. Paracetamol IV Introduction
11.4.4 Dr. Reddy's Laboratories Ltd. Revenue in Paracetamol IV Business (2018-2023)
11.4.5 Dr. Reddy's Laboratories Ltd. Recent Development
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Company Detail
11.5.2 Aurobindo Pharma Business Overview
11.5.3 Aurobindo Pharma Paracetamol IV Introduction
11.5.4 Aurobindo Pharma Revenue in Paracetamol IV Business (2018-2023)
11.5.5 Aurobindo Pharma Recent Development
11.6 Sun Pharmaceutical Industries Ltd.
11.6.1 Sun Pharmaceutical Industries Ltd. Company Detail
11.6.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.6.3 Sun Pharmaceutical Industries Ltd. Paracetamol IV Introduction
11.6.4 Sun Pharmaceutical Industries Ltd. Revenue in Paracetamol IV Business (2018-2023)
11.6.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Detail
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Paracetamol IV Introduction
11.7.4 Novartis AG Revenue in Paracetamol IV Business (2018-2023)
11.7.5 Novartis AG Recent Development
11.8 Pfizer, Inc.
11.8.1 Pfizer, Inc. Company Detail
11.8.2 Pfizer, Inc. Business Overview
11.8.3 Pfizer, Inc. Paracetamol IV Introduction
11.8.4 Pfizer, Inc. Revenue in Paracetamol IV Business (2018-2023)
11.8.5 Pfizer, Inc. Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Paracetamol IV Introduction
11.9.4 Abbott Revenue in Paracetamol IV Business (2018-2023)
11.9.5 Abbott Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Paracetamol IV Introduction
11.10.4 Sanofi Revenue in Paracetamol IV Business (2018-2023)
11.10.5 Sanofi Recent Development
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Detail
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Paracetamol IV Introduction
11.11.4 Bristol-Myers Squibb Company Revenue in Paracetamol IV Business (2018-2023)
11.11.5 Bristol-Myers Squibb Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Paracetamol IV Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Pain
Table 3. Key Players of Pyrexia (Fever)
Table 4. Global Paracetamol IV Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Paracetamol IV Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Paracetamol IV Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Paracetamol IV Market Share by Region (2018-2023)
Table 8. Global Paracetamol IV Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Paracetamol IV Market Share by Region (2024-2034)
Table 10. Paracetamol IV Market Trends
Table 11. Paracetamol IV Market Drivers
Table 12. Paracetamol IV Market Challenges
Table 13. Paracetamol IV Market Restraints
Table 14. Global Paracetamol IV Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Paracetamol IV Market Share by Players (2018-2023)
Table 16. Global Top Paracetamol IV Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paracetamol IV as of 2024)
Table 17. Ranking of Global Top Paracetamol IV Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Paracetamol IV Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Paracetamol IV Product Solution and Service
Table 21. Date of Enter into Paracetamol IV Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Paracetamol IV Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Paracetamol IV Revenue Market Share by Type (2018-2023)
Table 25. Global Paracetamol IV Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Paracetamol IV Revenue Market Share by Type (2024-2034)
Table 27. Global Paracetamol IV Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Paracetamol IV Revenue Market Share by Application (2018-2023)
Table 29. Global Paracetamol IV Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Paracetamol IV Revenue Market Share by Application (2024-2034)
Table 31. North America Paracetamol IV Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Paracetamol IV Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Paracetamol IV Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Paracetamol IV Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Paracetamol IV Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Paracetamol IV Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Paracetamol IV Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Paracetamol IV Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Paracetamol IV Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Paracetamol IV Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Paracetamol IV Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Paracetamol IV Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Paracetamol IV Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Paracetamol IV Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Paracetamol IV Market Size by Country (2024-2034) & (US$ Million)
Table 46. Mallinckrodt (Mallinckrodt Pharmaceuticals) Company Detail
Table 47. Mallinckrodt (Mallinckrodt Pharmaceuticals) Business Overview
Table 48. Mallinckrodt (Mallinckrodt Pharmaceuticals) Paracetamol IV Product
Table 49. Mallinckrodt (Mallinckrodt Pharmaceuticals) Revenue in Paracetamol IV Business (2018-2023) & (US$ Million)
Table 50. Mallinckrodt (Mallinckrodt Pharmaceuticals) Recent Development
Table 51. Cipla Inc. Company Detail
Table 52. Cipla Inc. Business Overview
Table 53. Cipla Inc. Paracetamol IV Product
Table 54. Cipla Inc. Revenue in Paracetamol IV Business (2018-2023) & (US$ Million)
Table 55. Cipla Inc. Recent Development
Table 56. Lupin Company Detail
Table 57. Lupin Business Overview
Table 58. Lupin Paracetamol IV Product
Table 59. Lupin Revenue in Paracetamol IV Business (2018-2023) & (US$ Million)
Table 60. Lupin Recent Development
Table 61. Dr. Reddy's Laboratories Ltd. Company Detail
Table 62. Dr. Reddy's Laboratories Ltd. Business Overview
Table 63. Dr. Reddy's Laboratories Ltd. Paracetamol IV Product
Table 64. Dr. Reddy's Laboratories Ltd. Revenue in Paracetamol IV Business (2018-2023) & (US$ Million)
Table 65. Dr. Reddy's Laboratories Ltd. Recent Development
Table 66. Aurobindo Pharma Company Detail
Table 67. Aurobindo Pharma Business Overview
Table 68. Aurobindo Pharma Paracetamol IV Product
Table 69. Aurobindo Pharma Revenue in Paracetamol IV Business (2018-2023) & (US$ Million)
Table 70. Aurobindo Pharma Recent Development
Table 71. Sun Pharmaceutical Industries Ltd. Company Detail
Table 72. Sun Pharmaceutical Industries Ltd. Business Overview
Table 73. Sun Pharmaceutical Industries Ltd. Paracetamol IV Product
Table 74. Sun Pharmaceutical Industries Ltd. Revenue in Paracetamol IV Business (2018-2023) & (US$ Million)
Table 75. Sun Pharmaceutical Industries Ltd. Recent Development
Table 76. Novartis AG Company Detail
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Paracetamol IV Product
Table 79. Novartis AG Revenue in Paracetamol IV Business (2018-2023) & (US$ Million)
Table 80. Novartis AG Recent Development
Table 81. Pfizer, Inc. Company Detail
Table 82. Pfizer, Inc. Business Overview
Table 83. Pfizer, Inc. Paracetamol IV Product
Table 84. Pfizer, Inc. Revenue in Paracetamol IV Business (2018-2023) & (US$ Million)
Table 85. Pfizer, Inc. Recent Development
Table 86. Abbott Company Detail
Table 87. Abbott Business Overview
Table 88. Abbott Paracetamol IV Product
Table 89. Abbott Revenue in Paracetamol IV Business (2018-2023) & (US$ Million)
Table 90. Abbott Recent Development
Table 91. Sanofi Company Detail
Table 92. Sanofi Business Overview
Table 93. Sanofi Paracetamol IV Product
Table 94. Sanofi Revenue in Paracetamol IV Business (2018-2023) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Bristol-Myers Squibb Company Company Detail
Table 97. Bristol-Myers Squibb Company Business Overview
Table 98. Bristol-Myers Squibb Company Paracetamol IV Product
Table 99. Bristol-Myers Squibb Company Revenue in Paracetamol IV Business (2018-2023) & (US$ Million)
Table 100. Bristol-Myers Squibb Company Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Paracetamol IV Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Paracetamol IV Market Share by Type: 2024 VS 2034
Figure 3. Pain Features
Figure 4. Pyrexia (Fever) Features
Figure 5. Global Paracetamol IV Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Paracetamol IV Market Share by Application: 2024 VS 2034
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Paracetamol IV Report Years Considered
Figure 11. Global Paracetamol IV Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global Paracetamol IV Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Paracetamol IV Market Share by Region: 2024 VS 2034
Figure 14. Global Paracetamol IV Market Share by Players in 2024
Figure 15. Global Top Paracetamol IV Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paracetamol IV as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Paracetamol IV Revenue in 2024
Figure 17. North America Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America Paracetamol IV Market Share by Country (2018-2034)
Figure 19. United States Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Canada Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Paracetamol IV Market Share by Country (2018-2034)
Figure 23. Germany Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. France Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. U.K. Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Italy Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Russia Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Nordic Countries Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Paracetamol IV Market Share by Region (2018-2034)
Figure 31. China Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Japan Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. South Korea Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Southeast Asia Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. India Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Australia Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Paracetamol IV Market Share by Country (2018-2034)
Figure 39. Mexico Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Brazil Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Paracetamol IV Market Share by Country (2018-2034)
Figure 43. Turkey Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Saudi Arabia Paracetamol IV Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Mallinckrodt (Mallinckrodt Pharmaceuticals) Revenue Growth Rate in Paracetamol IV Business (2018-2023)
Figure 46. Cipla Inc. Revenue Growth Rate in Paracetamol IV Business (2018-2023)
Figure 47. Lupin Revenue Growth Rate in Paracetamol IV Business (2018-2023)
Figure 48. Dr. Reddy's Laboratories Ltd. Revenue Growth Rate in Paracetamol IV Business (2018-2023)
Figure 49. Aurobindo Pharma Revenue Growth Rate in Paracetamol IV Business (2018-2023)
Figure 50. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Paracetamol IV Business (2018-2023)
Figure 51. Novartis AG Revenue Growth Rate in Paracetamol IV Business (2018-2023)
Figure 52. Pfizer, Inc. Revenue Growth Rate in Paracetamol IV Business (2018-2023)
Figure 53. Abbott Revenue Growth Rate in Paracetamol IV Business (2018-2023)
Figure 54. Sanofi Revenue Growth Rate in Paracetamol IV Business (2018-2023)
Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Paracetamol IV Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed